Predictive Oncology Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Sep 23 | SellUS$30,387 | Charles Nuzum | Individual | 10,000 | US$3.04 |
Insider Trading Volume
Insider-Käufe: Die Daten reichen nicht aus, um festzustellen, ob Insider in den letzten 3 Monaten mehr Aktien gekauft als verkauft haben.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 207.891 | 5,12 % |
Individual Insiders | 234.360 | 5,77 % |
Institutions | 317.820 | 7,82 % |
General Public | 3.303.010 | 81,3 % |
Verwässerung von Anteilen: Die Aktionäre wurden im vergangenen Jahr verwässert, wobei die Zahl der ausstehenden Aktien um 3.2% stieg.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
205.501 | US$402.8k | 0 % | no data | |||
140.604 | US$275.6k | 0 % | no data | |||
120.797 | US$236.8k | 2,17 % | no data | |||
104.585 | US$205.0k | 0 % | no data | |||
37.472 | US$73.4k | 0 % | no data | |||
26.639 | US$52.2k | 0 % | no data | |||
20.835 | US$40.8k | 0 % | 0,02 % | |||
20.835 | US$40.8k | 13,1 % | no data | |||
17.934 | US$35.2k | 0 % | no data | |||
16.960 | US$33.2k | 0 % | no data | |||
16.837 | US$33.0k | 0 % | no data | |||
14.665 | US$28.7k | 0 % | no data | |||
14.176 | US$27.8k | -16 % | no data | |||
10.358 | US$20.3k | 0 % | 0,03 % | |||
7.135 | US$14.0k | 0 % | no data | |||
7.122 | US$14.0k | 0 % | no data | |||
5.849 | US$11.5k | 0 % | no data | |||
5.451 | US$10.7k | 0 % | no data | |||
4.816 | US$9.4k | 2,03 % | no data | |||
2.679 | US$5.3k | 0,15 % | no data | |||
2.559 | US$5.0k | 3,65 % | no data | |||
2.390 | US$4.7k | 244 % | no data | |||
2.369 | US$4.6k | 0 % | no data | |||
425 | US$833.0 | -54,1 % | no data | |||
399 | US$782.0 | 0 % | no data |